Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Friedman, HS; Herndon, JE; McSherry, F; Ravelo, A; Lipp, ES; Healy, P; Peters, KB; Ranjan, T; Vlahovic, G; Watts, J; Sampson, JH; Friedman, AH; Desjardins, A

Published Date

  • May 20, 2014

Published In

Volume / Issue

  • 32 / 15_suppl

Start / End Page

  • 2082 - 2082

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2014.32.15_suppl.2082